Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)
0.0290
+0.0020 (7.41%)
At close: Sep 11, 2026
SGXC:9G2 Cash Flow Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -23.9 | -27.05 | -37.45 | -18.07 | -12.43 |
Depreciation & Amortization | 10.79 | 11.9 | 12.46 | 5.76 | 5.25 |
Other Amortization | - | 0.01 | 0.01 | 0.01 | 0.01 |
Loss (Gain) From Sale of Assets | -0.07 | - | -0.01 | -0.62 | -0.84 |
Asset Writedown & Restructuring Costs | 0.18 | 2.47 | - | -0.5 | -1.65 |
Stock-Based Compensation | - | 0.06 | -0.07 | -0.16 | 0.42 |
Provision & Write-off of Bad Debts | - | 0.04 | - | - | - |
Other Operating Activities | 3.75 | 2.76 | 16.42 | 5.24 | 0.97 |
Change in Accounts Receivable | -0.87 | -0.51 | 0.68 | 0.65 | -0.45 |
Change in Inventory | 0.01 | -0.01 | 0 | -0.01 | 0.01 |
Change in Accounts Payable | 6.51 | -0.32 | -5.03 | 4.4 | 2.2 |
Change in Other Net Operating Assets | -0.05 | 0.01 | 0.05 | 0.06 | 0.71 |
Operating Cash Flow | -3.65 | -10.65 | -12.93 | -3.24 | -5.81 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.49 | -0.15 | -0.53 | -14.44 | -4.09 |
Sale of Property, Plant & Equipment | 0.07 | - | 0.01 | - | 3.8 |
Sale (Purchase) of Intangibles | - | - | - | - | -0.02 |
Sale (Purchase) of Real Estate | - | - | - | 12.72 | 3.75 |
Other Investing Activities | 0.35 | 0.28 | 0.27 | 0.26 | 0.28 |
Investing Cash Flow | -0.07 | 0.13 | -0.26 | -1.45 | 3.72 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | - | 5 | 0.5 | 3.1 | - |
Long-Term Debt Issued | 7.2 | 12 | 7 | 21.82 | 24.74 |
Total Debt Issued | 7.2 | 17 | 7.5 | 24.92 | 24.74 |
Long-Term Debt Repaid | -5.31 | -5.25 | -25.73 | -21.27 | -14.2 |
Lease Payments | -2.98 | -2.63 | -2.51 | -2.28 | -2.09 |
Net Debt Issued (Repaid) | 1.89 | 11.75 | -18.23 | 3.64 | 10.54 |
Issuance of Common Stock | 12.62 | - | 26.22 | - | - |
Other Financing Activities | 1.32 | -1.73 | -0.07 | -3.74 | -2.7 |
Financing Cash Flow | 15.83 | 10.02 | 7.92 | -0.1 | 7.84 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Cash Flow | 12.11 | -0.5 | -5.27 | -4.79 | 5.75 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -4.14 | -10.8 | -13.46 | -17.68 | -9.89 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -26.31% | -68.74% | -80.88% | -108.89% | -71.66% |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.03 | -0.01 |
Levered Free Cash Flow | 0.93 | -4.04 | -27.05 | -19.34 | 3.48 |
Unlevered Free Cash Flow | 3.5 | -2.22 | -20.04 | -17.93 | 4.12 |
Free Cash Flow After Leases | -7.12 | -13.43 | -15.98 | -19.95 | -11.98 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 1.47 | 1.56 | 2.7 | 3.67 | 2.91 |
Change in Working Capital | 5.6 | -0.83 | -4.3 | 5.11 | 2.47 |